UroGen Pharma Ltd (URGN)
14.30
+0.04
(+0.28%)
USD |
NASDAQ |
May 03, 16:00
14.29
-0.01
(-0.07%)
After-Hours: 20:00
UroGen Pharma Max Drawdown (5Y): 92.16% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 92.16% |
| March 31, 2024 | 92.16% |
| February 29, 2024 | 92.16% |
| January 31, 2024 | 92.16% |
| December 31, 2023 | 92.16% |
| November 30, 2023 | 92.16% |
| October 31, 2023 | 92.16% |
| September 30, 2023 | 92.16% |
| August 31, 2023 | 92.16% |
| July 31, 2023 | 92.16% |
| June 30, 2023 | 92.16% |
| May 31, 2023 | 92.16% |
| April 30, 2023 | 92.16% |
| March 31, 2023 | 92.16% |
| February 28, 2023 | 92.16% |
| January 31, 2023 | 92.16% |
| December 31, 2022 | 92.16% |
| November 30, 2022 | 92.16% |
| October 31, 2022 | 92.16% |
| September 30, 2022 | 92.16% |
| August 31, 2022 | 92.16% |
| July 31, 2022 | 92.16% |
| June 30, 2022 | 92.16% |
| May 31, 2022 | 92.16% |
| April 30, 2022 | 90.94% |
| Date | Value |
|---|---|
| March 31, 2022 | 90.94% |
| February 28, 2022 | 90.94% |
| January 31, 2022 | 89.13% |
| December 31, 2021 | 86.18% |
| November 30, 2021 | 81.75% |
| October 31, 2021 | 79.06% |
| September 30, 2021 | 79.06% |
| August 31, 2021 | 79.06% |
| July 31, 2021 | 79.06% |
| June 30, 2021 | 79.06% |
| May 31, 2021 | 79.06% |
| April 30, 2021 | 79.06% |
| March 31, 2021 | 79.06% |
| February 28, 2021 | 79.06% |
| January 31, 2021 | 79.06% |
| December 31, 2020 | 79.06% |
| November 30, 2020 | 79.06% |
| October 31, 2020 | 79.06% |
| September 30, 2020 | 79.06% |
| August 31, 2020 | 79.06% |
| July 31, 2020 | 79.06% |
| June 30, 2020 | 79.06% |
| May 31, 2020 | 79.06% |
| April 30, 2020 | 79.06% |
| March 31, 2020 | 79.06% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
47.86%
Minimum
May 2019
92.16%
Maximum
May 2022
82.13%
Average
80.41%
Median
Max Drawdown (5Y) Benchmarks
| Agenus Inc | 96.18% |
| Exelixis Inc | 54.66% |
| Geron Corp | 86.09% |
| Protalix BioTherapeutics Inc | 94.35% |
| InfuSystems Holdings Inc | 71.55% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -31.59 |
| Beta (5Y) | 1.089 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 84.14% |
| Historical Sharpe Ratio (5Y) | -0.2312 |
| Historical Sortino (5Y) | -0.5309 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 30.05% |